Anika Therapeutics to Acquire Parcus Medical and Arthrosurface
Anika Therapeutics signed agreements to acquire Parcus Medical and Arthrosurface within 1Q20. Jan 06, 2020
Nextremity Solutions Gains Clearance for Lesser TMT Joint Arthrodesis System
Nextremity Solutions received FDA 510(k) clearance to market the InCore® TMT system, a three-part construct for fixation for Lesser Tarsometatarsal Joint Arthrodesis. Jan 06, 2020
Augmedics Launches xvision AR Surgical Guidance
Augmedics commenced the U.S. launch of the xvision™ augmented reality guidance system for spine surgery. Jan 06, 2020
SeaSpine Launches Mariner Midline Posterior Fixation
SeaSpine commenced the full commercial launch of the Mariner® Midline Posterior Fixation System, a less-invasive option to treat a range of spinal pathologies. Jan 06, 2020
Medacta Gains FDA Clearance for MyShoulder Placement Guides
Medacta was granted FDA 510(k) clearance to market MyShoulder Placement Guides for use with the Medacta Shoulder and associated instrumentation. Jan 06, 2020
OrthoPediatrics Launches QuickPack Bone Graft Substitute
OrthoPediatrics commenced U.S. launch of QuickPackâ„¢ synthetic bone graft substitute. Dec 20, 2019
Naviswiss Receives New Funding
Naviswiss closed a CHF 5 million (USD $5 million) round of private equity funding to support product development and entrance into new markets with its surgical navigation for joint replacement procedures. Dec 20, 2019
DePuy Synthes, Zebra Medical to Partner on AI in Orthopedics
Zebra Medical Vision and DePuy Ireland entered into a global co-development and commercialization agreement to bring artificial intelligence opportunities to orthopedics. Dec 19, 2019
Conventus Orthopaedics Acquires Intramedullary Technology from IntraFuse
Conventus Orthopaedics expanded into lower extremity orthopedics with an acquisition of all assets of IntraFuse, including proprietary intramedullary implants for the minimally invasive repair of fibula and other fractures. Dec 18, 2019
BioPoly Oversubscribes $2 Million Private Equity Offering
BioPoly fully subscribed its latest round of private equity financing of US $2 million. The round includes oversubscription funding of $890,000. Dec 18, 2019
